Pacific Biosciences Of California (PACB) Goodwill & Intangibles (2021 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Goodwill & Intangibles of $331.9 million for Q1 2026, down 1.21% year-over-year from $335.9 million in Q1 2025, and little changed quarter-over-quarter from $332.9 million in Q4 2025.
Pacific Biosciences Of California (PACB) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Pacific Biosciences Of California's Goodwill & Intangibles history runs 6 years deep, the most recent figure standing at $331.9 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 1.21% year-over-year to $331.9 million; the TTM figure through Mar 2026 stood at $331.9 million (down 1.21% YoY), while the FY2025 annual figure was $332.9 million, down 52.94% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $331.9 million, roughly flat from $332.9 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $925.7 million in Q3 2023, with the low at $331.9 million in Q1 2026.
- The 5-year median for Goodwill & Intangibles is $812.3 million (2024), against an average of $662.6 million.
- The sharpest annual moves came in 2022 and 2025: Goodwill & Intangibles surged 109.97% in 2022, then tumbled 63.18% in 2025.
- Pacific Biosciences Of California's Goodwill & Intangibles stood at $820.2 million in 2022, then plunged by 37.91% to $509.3 million in 2023, then jumped by 38.89% to $707.3 million in 2024, then slumped by 52.94% to $332.9 million in 2025, then declined by 0.31% to $331.9 million in 2026.
- Business Quant data shows PACB's Goodwill & Intangibles at $331.9 million in Q1 2026, $332.9 million in Q4 2025, and $333.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 419.38 Mn | 182.51 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 330.85 Mn |
| Mar 31, 2026 | 331.87 Mn |
| Dec 31, 2025 | 332.89 Mn |
| Sep 30, 2025 | 333.90 Mn |
| Jun 30, 2025 | 334.92 Mn |
| Mar 31, 2025 | 335.94 Mn |
| Dec 31, 2024 | 707.33 Mn |
| Sep 30, 2024 | 805.49 Mn |
| Jun 30, 2024 | 812.34 Mn |
| Mar 31, 2024 | 912.39 Mn |
| Dec 31, 2023 | 509.27 Mn |
| Sep 30, 2023 | 925.68 Mn |
| Jun 30, 2023 | 819.75 Mn |
| Mar 31, 2023 | 819.99 Mn |
| Dec 31, 2022 | 820.22 Mn |
| Sep 30, 2022 | 820.27 Mn |
| Jun 30, 2022 | 820.50 Mn |
| Mar 31, 2022 | 820.73 Mn |
| Dec 31, 2021 | 820.95 Mn |
| Sep 20, 2021 | 390.67 Mn |